CHESS

Featured Events

  • Established a world-class platform for clinical research and translational science in the field of liver health
  • Initiated 60+ international or domestic multi-center clinical research
  • Pioneered the Vasomics of the liver and extended it to the human vasculature
  • Founded programs for liver fibrosis screening in the general population in China
  • Promoted innovative technologies in 500+ hospitals across China and 30+ countries globally
  • Organized the Liver Health Development Forum (CHESS Annual Meeting)
  • Established Portal Hypertension Awareness and Prevention Day (December 6th)
  • Launched the "Qinggan Scholar" program for young hepatology scholars aged 35 or younger

Featured Publications

"Vasomics of the Liver"
Qi X, et al.
2025 Gut
"Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study"
Li W, Cao Z, et al.
2024 BMJ
"Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension"
Qi X, et al.
2018 Lancet Gastroenterol Hepatol
"The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis"
Shang Y, et al.
2025 Nat Med
"Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes"
Yip TC, Shang Y, et al.
2026 Gut
"Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model"
Qi X, et al.
2023 Radiology
"Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension"
Qi X, et al.
2019 Radiology
"Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease"
Zhou XD, et al.
2024 Hepatology
CHESS WeChat Official Account

Scan to follow for updates from CHESS